UNIVERSITY OF ALABAMA AT BIRMINGHAM
Birmingham, Alabama, United States
Jeevan Nammi, MBBS, is a Postdoctoral Research Fellow in the Division of Endocrinology, Diabetes, and Metabolism at the University of Alabama at Birmingham (UAB). His research focuses on metabolic liver disease, endocrinology, cancer therapeutics, and real-world outcomes research, with particular interests in MASLD/MASH, cardiometabolic disease, and treatment-related adverse events. He has presented work at national conferences including ENDO, AACE, and the American Heart Association Scientific Sessions, and has received recognition including the ENDO 2026 Early Career Award and Outstanding Abstract Award. Dr. Nammi is also pursuing a Master of Public Health at UAB, where his work integrates clinical medicine, epidemiology, and population health research.
Disclosure information not submitted.
ORF15-04 - Hyperandrogenism in the Absence of Metabolic Dysfunction Is Not Associated with MASLD
Saturday, June 13, 2026
2:00 PM - 2:15 PM CT
Saturday, June 13, 2026
2:45 PM - 3:00 PM CT
Sunday, June 14, 2026
9:00 AM - 4:00 PM CT